<DOC>
	<DOCNO>NCT00793585</DOCNO>
	<brief_summary>This prospective , randomize control study evaluate effect uric acid progression IgA nephropathy .</brief_summary>
	<brief_title>A Controlled Study Uric Acid Progression IgA Nephropathy</brief_title>
	<detailed_description>It report hyperuricemia risk factor progression IgAN . This prospective , randomize study . Eligible IgAN patient randomized treatment group control group . Patients treatment group receive allopurinol usual therapy . Patients control group receive usual therapy placebo . If hypertension , add CCB Î²-blocker . Fasting uric acid , serum creatinine , albumin , routine blood test , urine microscopy dipstick , proteinuria 24 hour blood pressure measure every month . After followed-up 6 month , curative effect Allopurinol blood pressure , proteinuria progression IgA nephropathy evaluate .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Uric Acid</mesh_term>
	<criteria>1 . Subjects either sex , 18 year old , range age 18 70 year old . 2 . Biopsyproven IgA nephropathy . 3 . Proteinuria 0.15g/d 3.0g/d ; serum albumin level &gt; 3.5g/dl . 4 . Serum creatinine &lt; 3 mg/dl . 5 . Uric acid &gt; 6 mg//dl ( 360umol/dl ) female ; Uric acid &gt; 7mg/dl ( 420umol/dl ) male . 6 . No history take ACEI ARB within 2 week . 7 . Blood pressure &lt; 180/110 mmHg . 8 . Subjects agree participate study sign inform consent . 1 . Patients receive prednisone immunosuppressive drug within 2 month . 2 . Patients must take ACEI ARB due disease . 3 . Patients history allergy allopurinol . 4 . Unwillingness follow study protocol . 5 . Active gout within 4 week . 6 . Pregnancy unwillingness use contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>IgA nephropathy</keyword>
</DOC>